{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:56:06Z","timestamp":1791186966938,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05667-y","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:10:01Z","timestamp":1785748201000},"page":"4483-4496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["YBX1-mediated m5C modification of exosomal LGALS3 derived from M2 tumor-associated macrophages drives colorectal cancer cell malignant behaviors"],"prefix":"10.1007","volume":"481","author":[{"given":"Lu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjie","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingmin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"5667_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kratzer TB (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345","DOI":"10.3322\/caac.21871"},{"key":"5667_CR2","doi-asserted-by":"crossref","unstructured":"Morgan E, Arnold M (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72(2):338\u2013344","DOI":"10.1136\/gutjnl-2022-327736"},{"issue":"7","key":"5667_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D (2021) Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA 325(7):669\u2013685","journal-title":"JAMA"},{"issue":"2","key":"5667_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","volume":"43","author":"R Abedizadeh","year":"2024","unstructured":"Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D (2024) Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev 43(2):729\u2013753","journal-title":"Cancer Metastasis Rev"},{"issue":"10207","key":"5667_CR5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394(10207):1467\u201380","journal-title":"Lancet"},{"issue":"5","key":"5667_CR6","first-page":"279","volume":"21","author":"M Bai-xiang","year":"2024","unstructured":"Bai-xiang M, Yuan xiang L, Hua jian Z, Ningyuan Y, Jin-yong Z, Min C (2024) Predicting and Validating the Mechanism of Action of the Enema Formula in Treating Colorectal Cancer by Using Network Pharmacology, GEO, and TCGA Databases. Curr Proteomics 21(5):279\u2013292","journal-title":"Curr Proteomics"},{"issue":"11\u201312","key":"5667_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.348226.120","volume":"35","author":"J Li","year":"2021","unstructured":"Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA (2021) Genetic and biological hallmarks of colorectal cancer. Genes Dev 35(11\u201312):787\u2013820","journal-title":"Genes Dev"},{"key":"5667_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L (2022) Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol 13:888713","journal-title":"Front Immunol"},{"key":"5667_CR9","doi-asserted-by":"crossref","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L et al (2024) Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol 8(1):31","DOI":"10.1038\/s41698-024-00522-z"},{"key":"5667_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jare.2024.02.009","volume":"68","author":"N Shao","year":"2025","unstructured":"Shao N, Qiu H, Liu J, Xiao D, Zhao J, Chen C et al (2025) Targeting lipid metabolism of macrophages: A new strategy for tumor therapy. J Adv Res 68:99\u2013114","journal-title":"J Adv Res"},{"key":"5667_CR11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201606","author":"X Bian","year":"2021","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z (2021) Lipid metabolism and cancer. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20201606","journal-title":"J Exp Med"},{"key":"5667_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021337","author":"SV Krylova","year":"2023","unstructured":"Krylova SV, Feng D (2023) The machinery of exosomes: biogenesis, release, and uptake. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021337","journal-title":"Int J Mol Sci"},{"key":"5667_CR13","doi-asserted-by":"crossref","unstructured":"Esfandyari S, Elkafas H (2021) Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy. Int J Mol Sci22(4):2165","DOI":"10.3390\/ijms22042165"},{"issue":"1","key":"5667_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12964-021-00808-w","volume":"20","author":"H Zhang","year":"2022","unstructured":"Zhang H, Xing J, Dai Z, Wang D, Tang D (2022) Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. Cell communication signaling: CCS 20(1):9","journal-title":"Cell communication signaling: CCS"},{"issue":"9","key":"5667_CR15","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.ymthe.2020.06.003","volume":"28","author":"W Guo","year":"2020","unstructured":"Guo W, Li Y, Pang W, Shen H (2020) Exosomes: a potential therapeutic tool targeting communications between tumor cells and macrophages. Mol Ther 28(9):1953\u201364","journal-title":"Mol Ther"},{"issue":"1","key":"5667_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12951-025-03321-1","volume":"23","author":"L Liu","year":"2025","unstructured":"Liu L, Zhang S, Ren Y, Wang R, Zhang Y, Weng S et al (2025) Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential. J Nanobiotechnol 23(1):319","journal-title":"J Nanobiotechnol"},{"key":"5667_CR17","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu M et al (2024) M2 Tumor-Associated Macrophages-Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression. Adv Sci (Weinh) 11(24):e2309298","DOI":"10.1002\/advs.202309298"},{"key":"5667_CR18","doi-asserted-by":"crossref","unstructured":"Song S, Zhao Y, Wang X, Tong X, Chen X (2023) M2 macrophages-derived exosomal miR-3917 promotes the progression of lung cancer via targeting GRK6. Biol Chem 404(1):41\u201357","DOI":"10.1515\/hsz-2022-0162"},{"key":"5667_CR19","doi-asserted-by":"crossref","unstructured":"Hou S, Zhao Y, Chen J, Lin Y, Qi X (2024) Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives. J Transl Med 22(1):62","DOI":"10.1186\/s12967-024-04856-x"},{"issue":"2","key":"5667_CR20","first-page":"599","volume":"41","author":"R Dong","year":"2018","unstructured":"Dong R, Zhang M, Hu Q, Zheng S, Soh A, Zheng Y et al (2018) Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). Int J Mol Med 41(2):599\u2013614","journal-title":"Int J Mol Med"},{"key":"5667_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1304735","volume":"14","author":"IM Seropian","year":"2023","unstructured":"Seropian IM, Cassaglia P, Miksztowicz V, Gonz\u00e1lez GE (2023) Unraveling the role of galectin-3 in cardiac pathology and physiology. Front Physiol 14:1304735","journal-title":"Front Physiol"},{"key":"5667_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.fsi.2019.10.043","volume":"95","author":"J Niu","year":"2019","unstructured":"Niu J, Huang Y, Liu X, Luo G, Tang J, Wang B et al (2019) Functional characterization of galectin-3 from Nile tilapia (Oreochromis niloticus) and its regulatory role on monocytes\/macrophages. Fish Shellfish Immunol 95:268\u2013276","journal-title":"Fish Shellfish Immunol"},{"issue":"1","key":"5667_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111564","volume":"28","author":"Y Fan","year":"2025","unstructured":"Fan Y, Song S, Pizzi MP, Zou G, Vykoukal JV, Yoshimura K et al (2025) Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations. iScience 28(1):111564","journal-title":"iScience"},{"key":"5667_CR24","doi-asserted-by":"crossref","unstructured":"Yuan W, Sun Q, Zhu X, Li B, Zou Y (2025) M2-polarized tumor-associated macrophage-secreted exosomal lncRNA NEAT1 upregulates galectin-3 by recruiting KLF5 and promotes HCC immune escape. J Cell Commun Signal 19(1):e12060","DOI":"10.1002\/ccs3.12060"},{"issue":"10","key":"5667_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152612","volume":"215","author":"C Wang","year":"2019","unstructured":"Wang C, Zhou X, Ma L, Zhuang Y, Wei Y, Zhang L et al (2019) Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: a meta-analysis. Pathol Res Pract 215(10):152612","journal-title":"Pathol Res Pract"},{"key":"5667_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1515\/med-2017-0032","volume":"12","author":"L Tao","year":"2017","unstructured":"Tao L, Jin L, Dechun L, Hongqiang Y, Changhua K, Guijun L (2017) Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis. Open Med 12:226\u201330","journal-title":"Open Med"},{"issue":"2","key":"5667_CR27","first-page":"524","volume":"31","author":"F Liu","year":"2025","unstructured":"Liu F, Ai F, Tang A, Yang Z, Li Z, Liu S (2025) Macrophage-Derived Exosomes Promoted the Development and Stemness of Inflammatory Bowel Disease-Related Colorectal Cancer via nuclear paraspeckle assembly transcript 1-Mediated miRNA-34a-5p\/phosphoprotein enriched in astrocytes 15 Axis. Inflamm Bowel Dis 31(2):524\u2013538","journal-title":"Axis"},{"key":"5667_CR28","doi-asserted-by":"crossref","unstructured":"Boxer E, Feigin N, Tschernichovsky R (2025) Emerging clinical applications of single-cell RNA sequencing in oncology. Nat Rev Clin Oncol 22(5):315\u2013326","DOI":"10.1038\/s41571-025-01003-3"},{"issue":"1","key":"5667_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi E, Satija R (2018) Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol 18(1):35\u201345","journal-title":"Nat Rev Immunol"},{"key":"5667_CR30","doi-asserted-by":"crossref","unstructured":"Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu H et al (2024) Metabolic Recoding of NSUN2-Mediated m(5)C Modification Promotes the Progression of Colorectal Cancer via the NSUN2\/YBX1\/m(5)C-ENO1 Positive Feedback Loop. Adv Sci (Weinh) 11(28):e2309840","DOI":"10.1002\/advs.202309840"},{"key":"5667_CR31","doi-asserted-by":"crossref","unstructured":"Duan Y, Li P, Yang Y, Wu G, Xing H, Chen H et al (2025) EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription. Cell Death Dis16(1):605","DOI":"10.1038\/s41419-025-07929-x"},{"key":"5667_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217737","volume":"624","author":"H Yuan","year":"2025","unstructured":"Yuan H, Qiu Y, Mei Z, Liu J, Wang L, Zhang K et al (2025) Cancer stem cells and tumor-associated macrophages: interactions and therapeutic opportunities. Cancer Lett 624:217737","journal-title":"Cancer Lett"},{"issue":"2","key":"5667_CR33","first-page":"91","volume":"21","author":"F Mao","year":"2017","unstructured":"Mao F, Kang JJ, Cai X, Ding NF, Wu YB, Yan YM et al (2017) Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Contemp Oncol (Poznan Poland) 21(2):91\u201397","journal-title":"Contemp Oncol (Poznan Poland)"},{"key":"5667_CR34","doi-asserted-by":"crossref","unstructured":"Mantovani A, Allavena P, Marchesi F (2022) Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov 21(11):799\u2013820","DOI":"10.1038\/s41573-022-00520-5"},{"issue":"4","key":"5667_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1615\/CritRevOncog.2024053830","volume":"29","author":"I Bui","year":"2024","unstructured":"Bui I, Bonavida B (2024) Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy. Crit Rev Oncog 29(4):75\u201395","journal-title":"Crit Rev Oncog"},{"key":"5667_CR36","doi-asserted-by":"publisher","first-page":"112319","DOI":"10.1016\/j.intimp.2024.112319","volume":"135","author":"Y Ren","year":"2024","unstructured":"Ren Y, Wang M, Yuan H, Wang Z, Yu L (2024) A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages. Int Immunopharmacol 135:112319","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"5667_CR37","first-page":"1181","volume":"48","author":"H Lee","year":"2025","unstructured":"Lee H, Park S, Lee J, Lee C, Kang H, Kang J et al (2025) Lipid metabolism in cancer stem cells: reprogramming, mechanisms, crosstalk, and therapeutic approaches. Cell Oncol (Dordrecht Netherlands) 48(5):1181\u20131201","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"issue":"9","key":"5667_CR38","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.7150\/ijbs.114222","volume":"21","author":"Y Li","year":"2025","unstructured":"Li Y, You J, Zou Z, Sun G, Shi Y, Sun Y et al (2025) Decoding the Tumor Microenvironment: Exosome-Mediated Macrophage Polarization and Therapeutic Frontiers. Int J Biol Sci 21(9):4187\u20134214","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5667_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40364-023-00538-w","volume":"11","author":"M Zhou","year":"2023","unstructured":"Zhou M, He X, Mei C, Ou C (2023) Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers. Biomark Res 11(1):100","journal-title":"Biomark Res"},{"key":"5667_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104881","volume":"215","author":"X Feng","year":"2025","unstructured":"Feng X, Zhang J, Yu B, An W, Jin X (2025) Lipid metabolic reprogramming in tumor-associated macrophages: a key driver of functional polarization and tumor immunomodulation. Crit Rev Oncol Hematol 215:104881","journal-title":"Crit Rev Oncol Hematol"},{"key":"5667_CR41","doi-asserted-by":"crossref","unstructured":"Yang Y, Ye H, Zhong D, Gao J, Yu M, Chen L et al (2026) M2 macrophages promote lymphatic metastasis by regulating PKM2 nuclear translocation in triple-negative breast cancer. Cell Death Dis 17(1)","DOI":"10.1038\/s41419-026-08524-4"},{"issue":"1","key":"5667_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41420-025-02623-5","volume":"11","author":"B Pang","year":"2025","unstructured":"Pang B, Wu H (2025) Metabolic reprogramming in colorectal cancer: a review of aerobic glycolysis and its therapeutic implications for targeted treatment strategies. Cell death discovery 11(1):321","journal-title":"Cell death discovery"},{"key":"5667_CR43","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang Q, Wang J, Wang C, Lan T, Wang T et al (2023) Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt\/\u03b2-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer. Int J Mol Sci24(18):14402","DOI":"10.3390\/ijms241814402"},{"key":"5667_CR44","doi-asserted-by":"crossref","unstructured":"Jiang Q, Zhao Q (2024) Galectin-3 impairs calcium transients and \u03b2-cell function. Nat Commun15(1):3682","DOI":"10.1038\/s41467-024-47959-1"},{"issue":"4","key":"5667_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/glycob\/cwy001","volume":"28","author":"P Nangia-Makker","year":"2018","unstructured":"Nangia-Makker P, Hogan V, Raz A (2018) Galectin-3 and cancer stemness. Glycobiology 28(4):172\u2013181","journal-title":"Glycobiology"},{"issue":"3","key":"5667_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","volume":"1863","author":"PP Ruvolo","year":"2016","unstructured":"Ruvolo PP (2016) Galectin 3 as a guardian of the tumor microenvironment. Biochim Biophys Acta 1863(3):427\u2013437","journal-title":"Biochim Biophys Acta"},{"key":"5667_CR47","doi-asserted-by":"crossref","unstructured":"Scafetta G, D\u2019Alessandria C, Bartolazzi A (2024) Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape. J Exp Clin Cancer Res 43(1):41","DOI":"10.1186\/s13046-024-02968-2"},{"key":"5667_CR48","doi-asserted-by":"crossref","unstructured":"Yu J, Zhang Y, Zhang J, Che P, Long G, Yang Z et al (2024) The m5C reader protein Ybx1 promotes axon growth by regulating local translation in axons. Development151(23):dev202781","DOI":"10.1242\/dev.202781"},{"key":"5667_CR49","doi-asserted-by":"crossref","unstructured":"Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y et al (2024) NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med14(3):e1621","DOI":"10.1002\/ctm2.1621"},{"issue":"5","key":"5667_CR50","first-page":"536","volume":"46","author":"X L\u00fc","year":"2021","unstructured":"L\u00fc X, Fan Y, Kang S, Xiao B, Zhang M (2021) RNA methylation and neurovascular unit remodeling. Zhong Nan Da Xue Xue Bao Yi Xue Ban 46(5):536\u201344","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"5667_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41419-025-08306-4","volume":"17","author":"Y Tang","year":"2025","unstructured":"Tang Y, Deng X, Wang Y, Zhou Q, Zhang C, Liu Z et al (2025) NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer. Cell Death Dis 17(1):75","journal-title":"Cell Death Dis"},{"key":"5667_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1702436","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Yuan Y, Jiang X, Wang Q (2025) Roles and mechanisms of NSUN2-mediated RNA m(5)C modification in cancer progression and immune modulation. Front Immunol 16:1702436","journal-title":"Front Immunol"},{"issue":"4","key":"5667_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100029","volume":"22","author":"L Wang","year":"2025","unstructured":"Wang L, Zhou D, Ou Y (2025) NSUN2\/FOXM1 positive feedback pathway promotes the malignant development of non-small cell lung cancer. Curr Proteomics 22(4):100029","journal-title":"Curr Proteomics"},{"issue":"28","key":"5667_CR54","doi-asserted-by":"publisher","first-page":"e2309840","DOI":"10.1002\/advs.202309840","volume":"11","author":"B Chen","year":"2024","unstructured":"Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu H et al (2024) Metabolic Recoding of NSUN2-Mediated m(5)C Modification Promotes the Progression of Colorectal Cancer via the NSUN2\/YBX1\/m(5)C-ENO1 Positive Feedback Loop. Adv Sci (Weinh) 11(28):e2309840","journal-title":"Adv Sci (Weinh)"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05667-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:09Z","timestamp":1791186309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05667-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5667"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05667-y","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of the First Affiliated Hospital of Henan Medical University [EC-LW026-053], and complied with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were performed in compliance with the ARRIVE guidelines and the Basel Declaration. All animals received humane care according to the National Institutes of Health (USA) guidelines. The assay was authorized by the Animal Ethics Committee of the the First Affiliated Hospital of Henan Medical University [EC-DW026-011].","order":4,"name":"Ethics","label":"Research involving human and animal participants","group":{"name":"EthicsHeading","label":"Declarations"}}]}}